Ginger has been studied to have value in over 150 health conditions with type 2 diabetes top on the list. With anti-diabetic drugs linked to increased cardiovascular mortality, natural alternatives are needed now more than ever. While ginger is widely used as a spice today, its role as a healing agent is often overlooked in modern society despite its thousands of years of documented use as a powerful medicine. Modern science, however, is finally catching up to the wisdom of the ancients. For instance, there are over 2100 published studies on the medicinal properties of ginger in the scientific literature, and the Greenmedinfo.com database contains evidence that it has value in over 170 different health conditions, and has over 50 different beneficial physiological effects. Notably, of all the conditions the research on ginger we have indexed reveals its therapeutic value for, type 2 diabetes is top on the list, with seven studies on our database providing proof of its efficacy.And the research keeps coming… Half a Billion At Risk for Type 2 Diabetes Type 2 diabetes is a metabolic disorder dominated by high blood sugar (hyperglycemia), but with inflammation and oxidative stress driving the damage most directly linked to morbidity and mortality associated with the condition.
In less than one month, four students at Monterey Park School have been diagnosed with pertussis, or whooping cough. Principal Brian Hayes and school officials met with parents to offer information and answer questions. “There really hasn’t been a feeling of fear. It’s been more of ‘what can we do to stop this?'” he said. “This is serious for parents that have younger children. This is a huge concern,” said one parent who wished to remain anonymous. The first case was diagnosed on Feb. 25. Three more students from the same fifth grade class also came down with the disease. “If there are students who are sick, we’re taking temperatures, we’re notifying parents. If they need to go to a physician, we’re doing that,” Director of Pupil Personnel Services Beatriz Chaidez said. Read
For people who have a few hundred thousand dollars to spend and are willing to take on the risks of an “early adopter” and travel to South America, options are now becoming available that were inconceivable just a few years ago. A new company is leapfrogging over the time-consuming process of testing and regulatory approval, and offering the best-established and most promising experimental anti-aging technologies in the near future. This is a new vision for combining research with treatment, for treating diseases that have no proven therapies, and for aging itself. You only have to read Time Magazineto notice that this is the year anti-aging medicine is coming of age. Promising life extension technologies are being debuted, with potential for preventing many diseases at once, adding decades to the human life span, and restoring youthful function to an aging body. These include telomerase therapies, stem cell therapies, epigenetic reprogramming, removal of senescent cells, plasma transfer, and hormonal therapies inspired by gene expression changes between young and old. Inevitably, this has brought a surge in the number of companies eager to jump the gun and offer treatments to consumers based on early lab research, before the technology has proved safe and effective
Recent outbreaks of Ebola, SARS, and other zoonotic infectious diseases that transmit from animals to humans have made the relationship between human disease and environmental management an especially hot topic. In East Africa, community ecologist Hillary Young’s fieldwork has examined the direct impacts of human disturbance on landscape and wildlife, as well as a variety of factors affecting infectious disease risk. Young posits that rodent-borne pathogens are likely to demonstrate the links between conservation and human health. In three recently published papers, she takes separate approaches to addressing the question of what human disturbance is doing to human health. “I ask this overarching question in a variety of ways,” says Young, an assistant professor in University of California, Santa Barbara’s department of ecology, evolution and marine biology. “All three papers try to come at that question from different directions, and acknowledge that there is no single answer. “We can disturb environments in myriad different ways, with diverse and cascading impacts across taxa—thus affecting disease risk in diverse and indirect ways,” she adds. Read
Jail is not supposed to be where you put the mentally ill or those too poor to pay bail. Nor is it supposed to be where African Americans, Hispanics, Native Americans and Asians go for crimes that don’t land white people behind bars. But that is what they are increasingly becoming. The primary purpose of jails, unlike prisons, is to be a temporary holding space where those who are a danger to the public or are a flight risk can await court proceedings. But they now hold many who are neither. Too often, jails are warehouses of low-risk individuals who are too poor to post bail or too sick for existing community resources to manage. Many jails today are being asked to do the job of mental health institutions, even though they lack the resources and expertise to treat people suffering from mental illness or substance abuse. Research shows that serious mental illness affects an estimated 14.5% of men in jails and 31% of women – rates that are three to six times higher than in the general population. Read
Doctors write millions of prescriptions a year for drugs to calm people with Alzheimer’s disease and other forms of dementia. But research suggests that non-drug approaches actually work better, and carry far fewer risks. A new study is the result of two decades’ worth of research on drugs like antipsychotics and antidepressants, and non-drug approaches that help caregivers address behavioral issues in dementia patients. The findings recommend that non-drug approaches that focus on training spouses, adult children, or staff in nursing homes and assisted living facilities should be the first choice for treating symptoms such as irritability, agitation, depression, anxiety, sleep problems, aggression, apathy, and delusions. TAILORED APPROACH To address this, researchers created DICE (Describe, Investigate, Evaluate, and Create), a framework that doctors and caregivers can use to make the most of what’s already known. The framework is tailored to each person with dementia and can be adapted as symptoms change. Read
Washington, Mar. 02 (ANI): The DNA strands on the end of chromosomes may help predict when people are going to die. BYU biologist Jonathan Alder stated that, DNA end caps, called telomeres, are the great predictors of life expectancy: the shorter your telomeres, the shorter your lifespan. But that’s not the only thing these fascinating strands of DNA predict. Shorter telomeres also indicate a greater chance for bone marrow failure, liver disease, skin disease and lung disease. Alder was currently studying the gene mutations that cause people to have unnaturally short telomeres. Recent research he coauthored with collaborators at Johns Hopkins University found those mutations are connected to both pulmonary fibrosis and emphysema. Telomeres are the protective tip of our chromosomes, kind of like the plastic cap on the end of a shoelace. Each time a cell divides and replicates, the DNA at the end of telomeres shorten. Since cell division happens throughout life, telomeres get shorter and shorter as we age. Read
“The history of cancer research has been a history of curing cancer in the mouse. We have cured mice of cancer for decades—and it simply didn’t work in humans.” This statement was made by Richard Klausner, M.D., former director of the National Cancer Institute, to the Los Angeles Times(Cimons 1998). It is a statement that applies equally to many other common diseases. A decade ago, researchers reported on the existence of 195 published methods that prevented or delayed the development of type 2 diabetes in mice (Roep et al 2004). Yet none of these “breakthroughs” ever translated to human medicine. What prevents successes in mice from becoming human cures and treatments? The reason is largely a simple one, as we showed when we recently analyzed the reputed contributions of mouse experiments to human type 2 diabetes research (Chandrasekera and Pippin 2013). Type 2 diabetes (diabetes mellitus) is the fastest-growing disease in the United States, currently affecting approximately 26 million Americans, and estimated to quadruple in prevalence to affect one-third of Americans by 2050 (CDC 2011a). Type 2 diabetes is the seventh leading cause of death in the United States (CDC 2011b). It is a complex and multifactorial disease, characterized by many